139 related articles for article (PubMed ID: 12545837)
1. [Effects of endothelin receptor antagonist on the hypoxic pulmonary hypertension].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):370-2, 386. PubMed ID: 12545837
[TBL] [Abstract][Full Text] [Related]
2. [The effect of ETA receptor antagonist WS009A on the pathogenesis of hypoxic pulmonary hypertension in rats].
Yang X; Chen W
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):409-12. PubMed ID: 12536579
[TBL] [Abstract][Full Text] [Related]
3. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
DiCarlo VS; Chen SJ; Meng QC; Durand J; Yano M; Chen YF; Oparil S
Am J Physiol; 1995 Nov; 269(5 Pt 1):L690-7. PubMed ID: 7491990
[TBL] [Abstract][Full Text] [Related]
4. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
5. [Expression of thrombospondin-1 in the lung of hypoxic pulmonary hypertension rats].
Yang YJ; Cheng DY; Zheng XW; Li F; Yang GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):19-23. PubMed ID: 22455124
[TBL] [Abstract][Full Text] [Related]
6. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
Oparil S; Chen SJ; Meng QC; Elton TS; Yano M; Chen YF
Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
[TBL] [Abstract][Full Text] [Related]
8. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
9. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.
Bonvallet ST; Zamora MR; Hasunuma K; Sato K; Hanasato N; Anderson D; Sato K; Stelzner TJ
Am J Physiol; 1994 Apr; 266(4 Pt 2):H1327-31. PubMed ID: 8184910
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
[TBL] [Abstract][Full Text] [Related]
11. [Changes of level and distribution of vascular endothelial growth factor in the lungs of rats with hypoxic pulmonary hypertension].
Chen W; Cheng D; Xiao X
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):237-40. PubMed ID: 10684081
[TBL] [Abstract][Full Text] [Related]
12. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
[TBL] [Abstract][Full Text] [Related]
13. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
15. [The expression of tyrosine-kinase receptor flk-1 and hypoxic pulmonary vascular remodeling in the lung of rats exposed to hypoxia].
Cheng D; Xiao X; Chen W
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):489-91. PubMed ID: 12528527
[TBL] [Abstract][Full Text] [Related]
16. Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension.
Pan P; Zhang X; Qian H; Shi W; Wang J; Bo Y; Li W
Exp Biol Med (Maywood); 2010 May; 235(5):642-8. PubMed ID: 20463305
[TBL] [Abstract][Full Text] [Related]
17. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats.
Eddahibi S; Raffestin B; Clozel M; Levame M; Adnot S
Am J Physiol; 1995 Feb; 268(2 Pt 2):H828-35. PubMed ID: 7864210
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension.
Haleen S; Schroeder R; Walker D; Quenby-Brown E; Welch K; Hallak H; Uprichard A; Keiser J
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S331-5. PubMed ID: 9595473
[TBL] [Abstract][Full Text] [Related]
19. [Changes of the gene expression of vascular endothelial growth factor in the lung of rats with chronic hypoxic pulmonary hypertension].
Chen W; Cheng D; Wu Q
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):233-6. PubMed ID: 10684080
[TBL] [Abstract][Full Text] [Related]
20. The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.
Sheedy W; Haleen S; Morice AH
Pulm Pharmacol Ther; 1998; 11(2-3):173-6. PubMed ID: 9918751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
